PRESS RELEASE published on 03/11/2026 at 09:00, 7 months 26 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj by NuWays AG analyzed: Clinical growth accelerates, profitability improves with increased share of wallet and workforce reductions. Target price EUR 3.8 Profitability NuWays AG Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 03/09/2026 at 09:05, 7 months 28 days ago Aiforia Technologies Oyj prête pour la croissance dans le segment clinique Partenariats Stratégiques Part De Marché Amélioration De L'EBITDA Expansion Des Revenus Croissance Clinique
BRIEF published on 03/09/2026 at 09:05, 7 months 28 days ago Aiforia Technologies Oyj Poised for Growth in Clinical Segment Strategic Partnerships Revenue Expansion EBITDA Improvement Market Share Clinical Growth
PRESS RELEASE published on 03/09/2026 at 09:00, 7 months 28 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's clinical segment shows strong growth with a clear roadmap for scaling, leading to improved profitability and strategic partnerships. Research recommends buying with a target price of EUR 3.80 Strategic Partnerships Profitability Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 02/27/2026 at 09:05, 8 months 7 days ago Aiforia Technologies Oyj Anticipates Strong Clinical Revenue Growth Strategic Partnerships AI Technology Profitability Financial Growth Clinical Revenue
BRIEF published on 02/27/2026 at 09:05, 8 months 7 days ago Aiforia Technologies Oyj anticipe une forte croissance de ses revenus cliniques Croissance Financière Rentabilité Partenariats Stratégiques Technologie IA Revenus Cliniques
PRESS RELEASE published on 02/27/2026 at 09:00, 8 months 7 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's updated research report by NuWays AG reveals accelerated clinical revenue growth expectations, with key focus on AI technology adoption and strategic partnerships for sales growth NuWays AG Research Report Aiforia Technologies Oyj Clinical Revenue Growth AI Technology Adoption
BRIEF published on 02/11/2026 at 09:05, 8 months 23 days ago La voie innovante vers la rentabilité d'Aiforia Technologies Oyj Rentabilité Imagerie Médicale Technologies Aiforia Transformateur De Vision Moteur De Fondation
BRIEF published on 02/11/2026 at 09:05, 8 months 23 days ago Aiforia Technologies Oyj's Innovative Path to Profitability Profitability Medical Imaging Aiforia Technologies Vision Transformer Foundation Engine
PRESS RELEASE published on 02/11/2026 at 09:00, 8 months 23 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj advances with new Foundation Engine technology for medical imaging, aiming for improved accuracy and scalability. Analyst recommends BUY with €3.80 target price Medical Imaging Scalability Accuracy Aiforia Technologies Oyj Foundation Engine
Published on 11/06/2026 at 22:15, 4 hours 16 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 13 hours 31 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 14 hours 1 minute ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 14 hours 1 minute ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 6 hours 16 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 6 hours 16 minutes ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 7 hours 16 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 7 hours 31 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 7 hours 59 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 19:06, 7 hours 24 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 7 hours 27 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 7 hours 29 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 7 hours 31 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
